San Raffaele Institute
A three-year project, led by the team of Prof. Guidotti, for the identification of new drugs against the Sars-CoV-2 virus and for the prevention of viral hepatitis infections.
The research aims to define vaccination and therapeutic strategies for effective and long-lasting protection against the Covid virus and its emerging variants.
The contribution of the SAME Foundation has enabled the creation and outfitting of biosafety environments and the installation of scientific equipment necessary for the research activity.
Lifetime Achievement Award, assigned by the HBV International Meeting in Kobe, Japan, to Prof. Luca Guidotti for his fundamental discoveries in the field of hepatitis B pathogenesis and antiviral development.
